Values as of: 2025-05-21
ETF | Trading--Leveraged Equity |
Last Closing
USD 38.89Change
-1.85 (-4.54)%Market Cap
N/AVolume
0.03MAnalyst Target
N/A
N/A
Verdict
Currency: USD
Country : USA
| Symbol | Name | Price(Change) | Market Cap |
|---|---|---|---|
| SOXL | Direxion Daily Semiconductor B.. |
-0.97 (-5.40%) |
USD 12.59B |
| FNGU | MicroSectors FANG+ Index 3X Le.. |
N/A |
USD 6.87B |
| QLD | ProShares Ultra QQQ |
-2.93 (-2.78%) |
USD 5.50B |
| SSO | ProShares Ultra S&P500 |
-3.02 (-3.34%) |
USD 4.33B |
| TECL | Direxion Daily Technology Bull.. |
-4.20 (-5.61%) |
USD 3.01B |
| UPRO | ProShares UltraPro S&P500 |
-4.09 (-5.01%) |
USD 2.91B |
| YINN | Direxion Daily FTSE China Bull.. |
-0.59 (-1.52%) |
USD 1.23B |
| USD | ProShares Ultra Semiconductors |
-2.01 (-3.63%) |
USD 0.61B |
| UDOW | ProShares UltraPro Dow30 |
-5.05 (-5.79%) |
USD 0.56B |
| LABU | Direxion Daily S&P Biotech Bul.. |
-4.22 (-7.63%) |
USD 0.53B |
| Symbol | Name | Weight | Mer | Price(Change) | Market Cap |
|---|---|---|---|---|---|
| KGHG | 4.13 % | 0.00 % |
N/A |
N/A | |
| IEUS | iShares MSCI Europe Small.. | 0.00 % | 0.40 % |
-0.45 (0%) |
USD 0.10B |
| SCZ | iShares MSCI EAFE Small-C.. | 0.00 % | 0.39 % |
-0.35 (0%) |
USD 9.36B |
| LGWU:F | Lyxor Index Fund - Lyxor .. | 0.00 % | 0.00 % |
-3.10 (0%) |
N/A |
| ZPRX:F | SSgA SPDR ETFs Europe II .. | 0.00 % | 0.00 % |
-0.71 (0%) |
USD 0.21B |
| ZPRX:XETRA | SPDR® MSCI Europe Small .. | 0.00 % | 0.00 % |
-0.16 (0%) |
N/A |
| 1388:TSE | 0.00 % | 0.00 % |
N/A |
N/A |
| Market Performance vs. Industry/Classification (Trading--Leveraged Equity) | Market Performance vs. Exchange | ||||||
| Value | Sector Median | Percentile Rank | Grade | Market Median | Percentile Rank | Grade | |
| YTD | |||||||
| Capital Gain | -11.59% | 42% | F | 18% | F | ||
| Dividend Return | N/A | N/A | N/A | N/A | N/A | ||
| Total Return | -11.59% | 42% | F | 17% | F | ||
| Trailing 12 Months | |||||||
| Capital Gain | -24.42% | 22% | F | 13% | F | ||
| Dividend Return | 1.17% | 77% | C+ | 24% | F | ||
| Total Return | -23.25% | 24% | F | 12% | F | ||
| Trailing 5 Years | |||||||
| Capital Gain | 34.54% | 33% | F | 50% | F | ||
| Dividend Return | 4.37% | 34% | F | 8% | B- | ||
| Total Return | 38.90% | 30% | F | 41% | F | ||
| Average Annual (5 Year Horizon) | |||||||
| Capital Gain | 7.07% | 31% | F | 62% | D | ||
| Dividend Return | 7.48% | 28% | F | 56% | F | ||
| Total Return | 0.41% | 23% | F | 10% | F | ||
| Risk Return Profile | |||||||
| Volatility (Standard Deviation) | 28.50% | 97% | N/A | 33% | F | ||
| Risk Adjusted Return | 26.24% | 47% | F | 44% | F | ||
| Market Capitalization | N/A | N/A | N/A | N/A | N/A | ||
| Target Price Action | Rating Action | Analyst | Rating | Price | Date |
|---|
This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.
The stock’s annual returns have been stable and consistent compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile. Although stability is good, also keep in mind it can limit returns.
This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.
The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.
The company has under performed its peers on annual average total returns in the past 5 years.
